Vancouver, British Columbia–(Newsfile Corp. – January 7, 2026) – Maple Gold Mines Ltd. (TSXV: MGM) (OTCQX: MGMLF) (FSE: M3G0) (“Maple Gold” or the “Company“) today announced the appointments with immediate effect of Dustin Isaacs, ICD.D as an Independent Director and Chair of Maple Gold’s Board of Directors (the “Board“) and Sarah Herriott, MBA as Vice […]
Canberra, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Online Casino Groups today announced the publication of a comprehensive evaluation report examining the seven most strategically significant gambling licenses in the international online casino industry. The study which can be viewed on the official Online Casino Groups AU website analyzes how different regulatory jurisdictions function as
NEW YORK CITY, NY / ACCESS Newswire / January 7, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Blue Owl Capital Inc. ("Blue Owl" or "the Company") (NYSE:OWL) and certain of its officers. Class Definition This lawsuit seeks to recover
Online Casino Groups releases comprehensive licensing evaluation report GlobeNewswire January 07, 2026 Canberra, Australia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Online Casino Groups today announced the publication of a comprehensive evaluation report examining the seven most strategically significant gambling licenses in the international online casino industry. The study which can be viewed on the official
(NASDAQ:RZLT), Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in both indications Company plans to meet with FDA to align on path forward for congenital HI REDWOOD CITY, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage
DUBAI, United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) has reported a 300% increase in its token price across Presale stages since the Presale began in early 2025. The project, which is building a decentralized lending and borrowing protocol, says the token has moved from $0.01 in Phase 1 to $0.04
(NasdaqGM:RAPP), U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second quarter of 2026 On strength of RAP-219 Phase 2a FOS data, epilepsy portfolio expanded with new program in primary generalized tonic-clonic seizures (PGTCS) Phase 2 trial
Mahe, Seychelles, Jan. 07, 2026 (GLOBE NEWSWIRE) — BitMart, a trusted global digital asset service provider, today announced its official partnership with CryptoKnights, the world's first reality-TV show centered on blockchain entrepreneurship. Through this landmark collaboration, BitMart CEO Nathan (Nenter) Chow will join Season 2's prestigious judging panel in several episodes of the season, bringing
(NasdaqGM:GANX), BETHESDA, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced its attendance at conferences during the week of the 44th Annual J.P. Morgan Healthcare Conference (“JPM week”)
(NASDAQ:GLUE), In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 driven inflammatory diseases, demonstrated rapid and durable reductions in systemic inflammation After four weeks of MRT-8102 treatment, C-reactive protein (CRP) levels were reduced by 85%, and 94% of study participants achieved CRP values